These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 11063124

  • 1. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B, Langan TA, Sclafani RA.
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [Abstract] [Full Text] [Related]

  • 2. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T, Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1998 Oct; 18(3A):1537-42. PubMed ID: 9673367
    [Abstract] [Full Text] [Related]

  • 3. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ.
    Cancer Res; 1995 Dec 15; 55(24):6200-9. PubMed ID: 8521414
    [Abstract] [Full Text] [Related]

  • 4. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL, McLean TI, Bachenheimer SL.
    Virology; 2000 Feb 15; 267(2):335-49. PubMed ID: 10662629
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M, Muller WJ, Singh G, Graham FL.
    Oncogene; 1999 Mar 04; 18(9):1663-76. PubMed ID: 10208428
    [Abstract] [Full Text] [Related]

  • 7. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
    Matsuo T, Thiele CJ.
    Oncogene; 1998 Jun 25; 16(25):3337-43. PubMed ID: 9681834
    [Abstract] [Full Text] [Related]

  • 8. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
    Sueoka N, Lee HY, Walsh GL, Hong WK, Kurie JM.
    Cancer Res; 1999 Aug 01; 59(15):3838-44. PubMed ID: 10447003
    [Abstract] [Full Text] [Related]

  • 9. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 1999 Jul 22; 18(29):4269-74. PubMed ID: 10435640
    [Abstract] [Full Text] [Related]

  • 10. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J, Wei T, Lahti JM, Kidd VJ.
    Cancer Res; 1998 Jun 15; 58(12):2624-32. PubMed ID: 9635589
    [Abstract] [Full Text] [Related]

  • 11. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Johnson DG, Conti CJ.
    Oncogene; 1998 Oct 29; 17(17):2251-8. PubMed ID: 9811455
    [Abstract] [Full Text] [Related]

  • 12. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A, Della Ragione F, Giordani L, Serra A, Saglio G, Faienza MF.
    Haematologica; 1998 Sep 29; 83(9):771-7. PubMed ID: 9825572
    [Abstract] [Full Text] [Related]

  • 13. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H, Wang YC.
    Sheng Li Ke Xue Jin Zhan; 1996 Apr 29; 27(2):107-12. PubMed ID: 9592231
    [Abstract] [Full Text] [Related]

  • 14. [Cyclin-dependent kinase inhibitory proteins in normal and transformed choroidal melanocytes].
    Mouriaux F, Maurage CA, Labalette P, Casagrande F, Malecaze F, Darbon JM.
    J Fr Ophtalmol; 1999 Apr 29; 22(3):339-46. PubMed ID: 10337591
    [Abstract] [Full Text] [Related]

  • 15. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ.
    Cancer Res; 2000 Jul 15; 60(14):3689-95. PubMed ID: 10919634
    [Abstract] [Full Text] [Related]

  • 16. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
    Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA, Lu X, Mittnacht S.
    EMBO J; 1999 Feb 01; 18(3):644-53. PubMed ID: 9927424
    [Abstract] [Full Text] [Related]

  • 17. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
    Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A.
    Cancer Res; 1995 Nov 15; 55(22):5168-72. PubMed ID: 7585567
    [Abstract] [Full Text] [Related]

  • 18. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

  • 19. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.
    Cancer Radiother; 2001 Apr 07; 5(2):109-29. PubMed ID: 11355576
    [Abstract] [Full Text] [Related]

  • 20. Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators.
    Suzuki-Takahashi I, Higashi H, Yoshida E, Nishimura S, Kitagawa M.
    Biochem Biophys Res Commun; 1997 May 19; 234(2):386-92. PubMed ID: 9177281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.